| Similar Articles |
|---|
 |
The Motley Fool
September 20, 2005
Jeremy MacNealy |
Chattem's Icy Hot Stock The stock of this manufacturer of over-the-counter health-care products is on an exceptional run. Shareholders may be wondering whether this is a good time to take some money off the table.   |
The Motley Fool
June 20, 2005
Matt Thurmond |
Chattem's High-Dollar Brands Health-care product maker generates big bucks from the body's annoying little problems. |
The Motley Fool
July 10, 2006
Stephen D. Simpson |
Chattem Holds Its Ground Management seems to have more faith in this consumer-goods company's business than Wall Street does. It is likely not a stock for the faint of heart. |
The Motley Fool
July 19, 2010
Eric Bleeker |
Procter & Gamble's Tricky Ambitions Can it maintain margins while moving further into value segments? |
The Motley Fool
March 26, 2007
Rich Duprey |
Breaking Chattem's Bond The consumer-products company should continue to give shareholders that soothing feeling. |
The Motley Fool
September 27, 2007
Ryan Fuhrmann |
Chattem Chugs Along Shares of Chattem hit a new high today on solid results, and management ups its guidance, but what does that mean going forward? Investors should take note. |
The Motley Fool
October 11, 2006
Brian Lawler |
Monopoly Woes Help Chattem Grow Acquisitions boost the health-care brand owner's shares to new highs. |
The Motley Fool
July 12, 2007
Jeremy MacNealy |
Fool on Call: Chattem Looks Toward a Record '08 Timely acquisitions and cost savings add up to a big year for this consumer-goods producer. Prospective investors should at least take a closer look. |
The Motley Fool
September 17, 2004
David Meier |
Gettin' Funky With Chattem Is Chattem good enough for your portfolio? |
The Motley Fool
July 11, 2007
Brian Orelli |
Icy Hot Results From Chattem The manufacturer of over-the-counter health-care products sees a huge increase in sales, but can it last? Investors, take note. |
The Motley Fool
September 28, 2011
Tamara Rutter |
A Recession-Proof Stock for Your Portfolio Is Procter & Gamble is a winning bet in a losing market? |
The Motley Fool
September 26, 2007
Ryan Fuhrmann |
Foolish Forecast: Will Chattem's Recent Results Prove Soothing? In advance of earnings reports at the health-care and consumer-products firm, analysts are projecting 47% year-over-year growth due to recently acquired brands. |
The Motley Fool
July 28, 2010
Sean Sun |
Risk Report Card: Procter & Gamble The power of its brands, from its Gillette razors to its Pampers diapers, gives it premium pricing power and an edge over its competitors. |
The Motley Fool
August 6, 2010
Matt Koppenheffer |
Unilever Versus the Consumer Slump Unilever announced second quarter results. |
The Motley Fool
May 10, 2006
Stephen D. Simpson |
A Broad Spectrum of Disappointment Will management at this company formerly known as Rayovac find a way to meet expectations? Investors, take note. |
The Motley Fool
October 12, 2005
Steven Mallas |
P&G Gambles on Prosperity Shareholders will have a nice stock on their hands for a while. Procter & Gamble sees steady growth four years out. |
The Motley Fool
August 25, 2009
Mike Pienciak |
Will P&G Ever Turn Around? Will the recently announced sale of its pharmaceutical business to specialty-drugs developer Warner Chilcott mark a turning point for Proctor & Gamble, or just another misstep? |
The Motley Fool
January 28, 2011
Matt Koppenheffer |
Procter & Gamble Shareholders Need Some Cheer Shares of Procter & Gamble take a dip after it announced fourth-quarter results. |
The Motley Fool
December 28, 2009
Mike Pienciak |
The Biggest No-Brainer Buys of 2009 (and 2010?) Shares of companies that sell everyday goods could've made you rich. 2009 was the year that the consumer-staples and generic foods sector became awfully interesting. |
The Motley Fool
July 16, 2010
Sean Sun |
Stock Cheat Sheet: Procter & Gamble If you're new to Procter & Gamble, consider this your cheat sheet to get introduced to the consumer products giant. |
The Motley Fool
August 20, 2010
Nate Weisshaar |
P&G to U.S. Consumer: It's Just Not Working Anymore The company is moving on to the rest of the world. |
The Motley Fool
November 6, 2007
Saibal Saha |
The Power of Global Brands Corporate brands provide tremendous marketing leverage, however, a company that has a lot riding on its brand runs the risk that one unfavorable issue will affect the entire business. There are pros and cons to this strategy. |
The Motley Fool
October 29, 2008
Colleen Paulson |
This Stock Isn't a Gamble Good old Procter & Gamble produced its usual respectable first-quarter earnings, highlighted by 9% revenue growth and 12% EPS gains in the wake of rising commodity costs. |
The Motley Fool
March 19, 2007
Rich Duprey |
Foolish Forecast: Chatting Up Chattem The consumer products company will report first-quarter 2007 financial results shortly. Investors, here is what you can expect to see. |
The Motley Fool
May 17, 2006
Stephen D. Simpson |
Better Days in Sight for Church & Dwight The transition from acquirer to operator isn't easy, but the company seems to be managing. The market seems to know that, as these shares aren't priced for value investors, even if you give them some pretty healthy benefits of the doubt. |
The Motley Fool
September 20, 2004
Nathan Slaughter |
Colgate-Palmolive Washed Away The consumer products firm issues a profit warning for the second half. Investors reacted harshly to the dim forecast, driving the stock 10% lower to a multiyear low of $48.38. |
The Motley Fool
February 13, 2007
Rich Duprey |
Chattem Has Relief on the Way The consumer products company has a portfolio of new products to drive revenues and profits. Investors, take note. |
The Motley Fool
March 14, 2006
Seth Jayson |
P&G Gets Nicked Procter & Gamble shares dropped 2.5% after the firm released EPS guidance that didn't quite meet Wall Street's fancy. Investors, too bad the blip's not bigger. |
The Motley Fool
July 27, 2005
W.D. Crotty |
Good Quarter for a 35-Bagger Colgate-Palmolive reports strong second-quarter sales. It's steady, almost predictable growth, and a 2.1% dividend, make the stock a consideration for conservative investors looking for stocks to lock away for the long term. |
The Motley Fool
May 11, 2006
Stephen D. Simpson |
Looking for Leverage With Unilever Investors, if you are worried that you missed out on Unilever, don't be. It's gone almost exactly nowhere in the past year. That doesn't mean that the turnaround isn't coming along, though. |
The Motley Fool
August 18, 2011
Tony Luckett |
2 Consumer Giants Predict the Future P&G and Unilever can indicate the health of the global economy. |
The Motley Fool
April 27, 2006
Steven Mallas |
Colgate's Cool Quarter Colgate-Palmolive didn't have a spectacular quarter, but it's still a good investment idea. |
The Motley Fool
August 5, 2011
Piper Terrett |
Unilever Battles the Downturn Unilever, the company behind Lynx and Dove, looks cheap compared to its rivals. |
The Motley Fool
October 1, 2009
Mike Pienciak |
2 Big Reasons to Love Colgate-Palmolive The bullish argument about Colgate-Palmolive is that it boasts superior margins and a resilient product portfolio. |
The Motley Fool
September 27, 2007
Timothy M. Otte |
Who Has the Best Brands? Take a closer look at seven of the largest consumer brand companies: Proctor & Gamble... PepsiCo... Coca-Cola... Colgate-Palmolive... Unilever... General Mills... Kraft... |
The Motley Fool
May 12, 2008
Timothy M. Otte |
Unilever Munches on Cheesy Profits Steady growth and sale proceeds drive a solid first quarter for the consumer products company. |
The Motley Fool
July 10, 2006
Stephen D. Simpson |
Same Old Look at Helen of Troy Another quarter goes by without clear signs of progress. Investors, take note. |
The Motley Fool
July 17, 2006
Stephen D. Simpson |
Spectrum Finds New Lows For investors who've stuck with this troubled maker of batteries, shavers, and fish food, today's 29% drop in the stock is just another kick to the gut. |
The Motley Fool
December 22, 2009
Brian Orelli |
This Acquisition Is Icy Hot Expensive price, but Chattem may still be a good buy for sanofi-aventis. |
The Motley Fool
July 6, 2009
Rick Aristotle Munarriz |
7 Reasons Not to Worry This Week Not every company will be posting lower earnings this week. Take a look at these three that are projected to grow: Chattem... Family Dollar... Kayne Anderson Energy... |
The Motley Fool
March 25, 2011
Brian Orelli |
Teva:P&G :: Peanut Butter:Chocolate The generic-drug maker and consumer-products company are forming a joint venture to sell over-the-counter medication, with both companies bringing their strengths to the table. |
The Motley Fool
May 9, 2006
Stephen D. Simpson |
Uneven Progress at Helen of Troy Unfortunately, this beauty's still got some warts. However, a bargain is still a bargain. Investors, tread carefully, though, and keep an eye out for this year's proxy statement. |
